Successful sequential chemo-immunotherapy and reduced-volume brachytherapy for bulky residual cervical tumor after external beam radiotherapy: two case reports
Sequential chemo-immunotherapy followed by reduced-volume BT may represent an alternative treatment option for patients with bulky residual disease after EBRT. Further clinical studies are warranted to validate the effectiveness of this combined regimen.
Authors
- Meiping Jiang (ORCID: https://orcid.org/0000-0002-1977-997X)
- Chunfang Zhao (ORCID: https://orcid.org/0000-0002-1744-8130)
- Conghui Ai
- Lan Zhang (ORCID: https://orcid.org/0000-0002-7572-1035)
- Zheng Li (ORCID: https://orcid.org/0000-0002-6141-4990)
- Shuhui Yu (ORCID: https://orcid.org/0000-0003-0219-6564)
- Xingrao Wu
- Kangming Li (ORCID: https://orcid.org/0009-0005-2927-3920)
Institutions
- Kunming Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-11-19
- DOI
- https://doi.org/10.3389/fimmu.2025.1687247
- Citations
- 1
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.06
Funders
- National Natural Science Foundation of China